293 related articles for article (PubMed ID: 24858854)
1. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
[TBL] [Abstract][Full Text] [Related]
2. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
[TBL] [Abstract][Full Text] [Related]
3. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
Kinsella MG; Irvin C; Reidy MA; Wight TN
Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
[TBL] [Abstract][Full Text] [Related]
4. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
[TBL] [Abstract][Full Text] [Related]
6. Sonic hedgehog-dependent activation of adventitial fibroblasts promotes neointima formation.
Dutzmann J; Koch A; Weisheit S; Sonnenschein K; Korte L; Haertlé M; Thum T; Bauersachs J; Sedding DG; Daniel JM
Cardiovasc Res; 2017 Nov; 113(13):1653-1663. PubMed ID: 29088375
[TBL] [Abstract][Full Text] [Related]
7. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
[TBL] [Abstract][Full Text] [Related]
9. Changes in perlecan expression during vascular injury: role in the inhibition of smooth muscle cell proliferation in the late lesion.
Kinsella MG; Tran PK; Weiser-Evans MC; Reidy M; Majack RA; Wight TN
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):608-14. PubMed ID: 12615671
[TBL] [Abstract][Full Text] [Related]
10. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
[TBL] [Abstract][Full Text] [Related]
11. Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report.
Ran R; Cai D; King SD; Que X; Bath JM; Chen SY
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):808-814. PubMed ID: 33267655
[TBL] [Abstract][Full Text] [Related]
12. Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.
Shi N; Li CX; Cui XB; Tomarev SI; Chen SY
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):446-454. PubMed ID: 28062493
[TBL] [Abstract][Full Text] [Related]
13. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.
Wang YC; Cui XB; Chuang YH; Chen SY
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1352-1360. PubMed ID: 28473442
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia.
Fukai N; Kenagy RD; Chen L; Gao L; Daum G; Clowes AW
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1356-62. PubMed ID: 19592464
[TBL] [Abstract][Full Text] [Related]
15. Protein Z-deficiency is associated with enhanced neointima formation and inflammatory response after vascular injury in mice.
Butschkau A; Wagner NM; Bierhansl L; Genz B; Vollmar B
Int J Clin Exp Pathol; 2014; 7(9):6064-71. PubMed ID: 25337252
[TBL] [Abstract][Full Text] [Related]
16. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors.
Pruthi D; McCurley A; Aronovitz M; Galayda C; Karumanchi SA; Jaffe IZ
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):355-64. PubMed ID: 24311380
[TBL] [Abstract][Full Text] [Related]
18. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
19. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
Tzeng BH; Chen YH; Huang CH; Lin SS; Lee KR; Chen CC
Cardiovasc Res; 2012 Dec; 96(3):533-42. PubMed ID: 22886848
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization.
Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
